New MRI dye tested against standard for clearer kidney scans
NCT ID NCT07040865
Summary
This study aims to see if a newer MRI contrast agent (gadopiclenol) works as well as the current standard agent (gadobutrol) for getting clear pictures of the kidneys and adrenal glands. About 104 adults with incidental findings on these organs will be randomly assigned to receive one of the two agents during a single 60-minute MRI scan. The main goal is to compare how well each agent highlights the tissue in the images.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUSPECT RENAL AND ADRENAL IMAGING FINDINGS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Diagnostic, Interventional and Pediatric Radiology Inselspital, University of Bern
RECRUITINGBern, 3010, Switzerland
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.